263 results on '"CONTINUOUS ambulatory peritoneal dialysis"'
Search Results
2. Malassezia
3. Latin America
4. Dialysis and Contrast Media
5. Nutrition for the Critically Ill Pediatric Patient with Renal Dysfunction
6. Endoscopic Surgery for Peritoneal Dialysis Catheters in Children
7. Dialysis and Contrast Media
8. Chapter 9 Patients and EHRs Tele Home Monitoring Reference Scenario
9. Abdominal Tuberculosis
10. Other Nonneoplastic Pathologies
11. Laparoscopic Insertion of Peritoneal Dialysis Catheters in Children
12. Intra-abdominal Complications in Peritoneal Dialysis with Special Reference to Peritoneal Fibrosis
13. Prostaglandin Synthesis of Human Mesothelial Cells In Vitro Is Regulated by Transforming Growth Factor-β 1, Tumor Necrosis Factor-α, and Interleukin-1β
14. Adequacy of Renal Replacement Therapy
15. Drug Use in Critically Ill Patients with Acute Renal Failure
16. Use of Monophosphoryl Lipid A as a Prophylactic for Sepsis and Shock
17. Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country
18. Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin
19. Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells
20. Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients
21. Erythropoietin Treatment in Children with Renal Anemia
22. Calcium, Phosphorus, Aluminum, and Bone Disease in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
23. Understanding the Kinetics of Peritoneal Transport
24. Comparing the Adequacy of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis
25. The Impact of the Y-System and Low Peritonitis Rate on CAPD Results
26. Pharmacological Alteration of Ultrafiltration
27. Overview of Continuous Ambulatory Peritoneal Dialysis —1990
28. Malignancy and Cystic Disease
29. Electrophysiological and Biofunctional Abnormalities in Uremic Neuropathy
30. Hypotheses, Basal Conditions, and Facts in the Provision and Allocation of Renal Replacement Therapy in Germany
31. Excuses of Nephrologists Not to Transplant
32. Closed Continuous Postoperative Peritoneal Lavage in Diffuse Bacterial Peritonitis
33. A Home-Care Project for Cancer Patients in Germany: Background and Experiences
34. Competitive Protein-Binding Assay for the Diagnosis of Hyper- and Hypovitaminosis D
35. Utility Analysis in Socioeconomic Evaluation
36. Video-assisted thoracic surgery for pleuroperitoneal communication
37. Nierenersatztherapie bei Älteren
38. Raoultella planticola peritonitis in a patient on continuous ambulatory peritoneal dialysis
39. Monocyte-Macrophage Mediated Suppression of Erythropoiesis in Renal Anemia
40. LP-X and Other Abnormal Lipoprotein Particles in Secondary Dyslipoproteinemia
41. Enhanced Peritoneal Generation of Vasoactive Prostaglandins during Peritonitis in Patients Undergoing CAPD
42. Sclerosing Encapsulating Peritonitis during CAPD. Evaluation of the Potential Risk Factors
43. Sclerosing Encapsulating Peritonitis and Other Complications of CAPD Peritonitis
44. Sclerosing Peritonitis—A Further Complication of CAPD
45. Hazards of CAPD: Interleukin-1 Production
46. No Difference Between Oral and Intraperitoneal Treatment of CAPD Peritonitis with Cephradine
47. Defective Peritoneal Polymorphonuclear Leukocyte Function in Patients on Intermittent Peritoneal Dialysis: Effects of Some Divalent Ions and Fibronectin
48. Comparison of Lymphocyte Markers and Lymphoblastic Transformation Studies of Patients Converted from Hemodialysis to CAPD
49. Immunoglobulins in CAPD
50. The Importance of Intracellular Organisms in CAPD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.